HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sato, T. Articles by Okada, H. Search for Related Content PubMed PubMed Citation Articles by Sato, T. Articles by Okada, H.

Pro-Carboxypeptidase R is an Acute Phase Protein in the Mouse, Whereas Carboxypeptidase N Is Not^{1 ,2}

Tomoo Sato^*,, Takashi Miwa^*,, Hiroyasu Akatsu, Noriyuki Matsukawa, Kyoko Obata^*, Noriko Okada^*, William Campbell and Hidechika Okada^3,*

^* Department of Molecular Biology, Nagoya City University Medical School, Nagoya, Japan; and Choju Medical Institute, Fukushimura Hospital, Toyohashi, Japan

Carboxypeptidase R (EC 3.4.17.20; CPR) and carboxypeptidase N (EC 3.4.17.3; CPN) cleave carboxyl-terminal arginine and lysine residues from biologically active peptides such as kinins and anaphylatoxins, resulting in regulation of their biological activity. Human proCPR, also known as thrombin-activatable fibrinolysis inhibitor, plasma pro-carboxypeptidase B, and pro-carboxypeptidase U, is a plasma zymogen activated during coagulation. CPN, however, previously termed kininase I and anaphylatoxin inactivator, is present in a stable active form in plasma. We report here the isolation of mouse proCPR and CPN cDNA clones that can induce their respective enzymatic activities in culture supernatants of transiently transfected cells. Potato carboxypeptidase inhibitor can inhibit carboxypeptidase activity in culture medium of mouse proCPR-transfected cells. The expression of proCPR mRNA in murine liver is greatly enhanced following LPS injection, whereas CPN mRNA expression remains unaffected. Furthermore, the CPR activity in plasma increased 2-fold at 24 h after LPS treatment. Therefore, proCPR can be considered a type of acute phase protein, whereas CPN is not. An increase in CPR activity may facilitate rapid inactivation of inflammatory mediators generated at the site of Gram-negative bacterial infection and may consequently prevent septic shock. In view of the ability of proCPR to also inhibit fibrinolysis, an excess of proCPR induced by LPS may contribute to hypofibrinolysis in patients suffering from disseminated intravascular coagulation caused by sepsis.

This article has been cited by other articles:

				N. Okumura, T. Koh, Y. Hasebe, T. Seki, and T. Ariga A Novel Function of Thrombin-activatable Fibrinolysis Inhibitor during Rat Liver Regeneration and in Growth-promoted Hepatocytes in Primary Culture J. Biol. Chem., June 12, 2009; 284(24): 16553 - 16561. [Abstract] [Full Text] [PDF]

				M. E. Meltzer, C. J.M. Doggen, P. G. de Groot, J. C.M. Meijers, F. R. Rosendaal, and T. Lisman Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men Haematologica, June 1, 2009; 94(6): 811 - 818. [Abstract] [Full Text] [PDF]

				T. M. Binette, F. B. Taylor Jr, G. Peer, and L. Bajzar Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon Blood, November 1, 2007; 110(9): 3168 - 3175. [Abstract] [Full Text] [PDF]

				J. L. Willemse and D. F. Hendriks Measurement of Procarboxypeptidase U (TAFI) in Human Plasma: A Laboratory Challenge Clin. Chem., January 1, 2006; 52(1): 30 - 36. [Abstract] [Full Text] [PDF]

				R. Renckens, J. J. T. H. Roelofs, S. A. J. ter Horst, C. van 't Veer, S. R. Havik, S. Florquin, G. T. M. Wagenaar, J. C. M. Meijers, and T. van der Poll Absence of Thrombin-Activatable Fibrinolysis Inhibitor Protects against Sepsis-Induced Liver Injury in Mice J. Immunol., November 15, 2005; 175(10): 6764 - 6771. [Abstract] [Full Text] [PDF]

				D. A. Davis, K. E. Singer, M. De La Luz Sierra, M. Narazaki, F. Yang, H. M. Fales, R. Yarchoan, and G. Tosato Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1{alpha} in the circulation Blood, June 15, 2005; 105(12): 4561 - 4568. [Abstract] [Full Text] [PDF]

				S. Asai, T. Sato, T. Tada, T. Miyamoto, N. Kimbara, N. Motoyama, H. Okada, and N. Okada Absence of Procarboxypeptidase R Induces Complement-Mediated Lethal Inflammation in Lipopolysaccharide-Primed Mice J. Immunol., October 1, 2004; 173(7): 4669 - 4674. [Abstract] [Full Text] [PDF]

				M. B. Boffa, J. D. Hamill, D. Maret, D. Brown, M. L. Scott, M. E. Nesheim, and M. L. Koschinsky Acute Phase Mediators Modulate Thrombin-activable Fibrinolysis Inhibitor (TAFI) Gene Expression in HepG2 Cells J. Biol. Chem., March 7, 2003; 278(11): 9250 - 9257. [Abstract] [Full Text] [PDF]

				M. B. Boffa, J. D. Hamill, N. Bastajian, R. Dillon, M. E. Nesheim, and M. L. Koschinsky A Role for CCAAT/Enhancer-binding Protein in Hepatic Expression of Thrombin-activable Fibrinolysis Inhibitor J. Biol. Chem., July 5, 2002; 277(28): 25329 - 25336. [Abstract] [Full Text] [PDF]

				V. V. Kakkar, D. A. Hoppenstead, J. Fareed, Z. Kadziola, M. Scully, R. Nakov, and H. K. Breddin Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis Blood, March 15, 2002; 99(6): 1965 - 1970. [Abstract] [Full Text] [PDF]

				K. W. Matthews and R. A. Wetsel Characterization of Mouse Carboxypeptidase N Small Active Subunit Gene Structure J. Immunol., May 15, 2001; 166(10): 6196 - 6202. [Abstract] [Full Text] [PDF]